Correct BID Dose for Amoxicillin in Bacterial Sinus Infection
For an otherwise healthy adult with acute bacterial sinusitis, the correct twice-daily (BID) dose of amoxicillin is 500 mg every 12 hours for mild-to-moderate infections, or 875 mg every 12 hours for severe infections or when resistant organisms are suspected. 1, 2
Standard Dosing for Uncomplicated Cases
For most adults with uncomplicated acute bacterial rhinosinusitis (ABRS), amoxicillin 500 mg every 12 hours is the appropriate starting dose 2. This recommendation comes directly from FDA labeling and is supported by the 2015 American Academy of Otolaryngology guidelines, which identify amoxicillin as first-line therapy due to its safety, efficacy, low cost, and narrow microbiologic spectrum 1.
The FDA-approved dosing table specifically lists 500 mg every 12 hours for ear/nose/throat infections of mild to moderate severity in adults 2.
High-Dose Therapy: When to Escalate to 875 mg BID
Escalate to amoxicillin 875 mg every 12 hours when any of these factors are present 1:
- Severe infection (fever ≥39°C/102°F, severe facial pain, systemic toxicity)
- Recent antibiotic use (within past month)
- Geographic areas with high penicillin-resistant S. pneumoniae (>10% prevalence)
- Age >65 years
- Recent hospitalization
- Immunocompromised status
- Comorbidities (diabetes, chronic cardiac/hepatic/renal disease)
- Frontal or sphenoidal sinusitis
The rationale for high-dose therapy is to overcome penicillin-nonsusceptible Streptococcus pneumoniae through higher tissue concentrations 1.
Duration of Treatment
Treat for 5-7 days in most cases, though traditional 10-day courses remain acceptable 1. The 2015 guidelines note that systematic reviews have not shown consistent benefits for 10-day therapy compared with shorter courses, and adverse events are reduced with shorter duration 1.
Important Caveats
Amoxicillin-clavulanate is NOT the same as amoxicillin alone. If prescribing amoxicillin-clavulanate instead (which some guidelines prefer as first-line), the high-dose formulation is 2000 mg amoxicillin component (2 grams) every 12 hours, not 875 mg 3, 1, 3. This distinction is critical—the 875 mg dose refers to amoxicillin monotherapy, while amoxicillin-clavulanate high-dose requires doubling to 2 grams of the amoxicillin component.
Common prescribing error: The 2024 epidemiologic study found that macrolides (erythromycins) were prescribed 25.8% of the time as first-line therapy for acute sinusitis 4, despite guidelines specifically recommending against them due to high S. pneumoniae resistance rates (>40%) 1. This represents a significant deviation from evidence-based practice.
Pharmacokinetic Support
Research demonstrates that 1000 mg amoxicillin twice daily produces equivalent or superior tissue concentrations compared to 500 mg three times daily in both acute and chronic sinusitis 5, 6. Median nasal secretion concentrations were 2.34 μg/mL with BID dosing versus 1.95 μg/mL with TID dosing, with no statistical difference in bioavailability 6. Both regimens exceeded minimum inhibitory concentrations for common pathogens.
A 1998 trial confirmed that amoxicillin-clavulanate 875/125 mg every 12 hours was as effective and safe as 500/125 mg every 8 hours, with 93% versus 88% clinical success rates respectively 7.
When Amoxicillin Alone May Not Be Appropriate
Consider amoxicillin-clavulanate instead of amoxicillin monotherapy when β-lactamase-producing organisms (H. influenzae, M. catarrhalis) are likely, particularly with recent antibiotic exposure, daycare contact, or treatment failure 1. However, for penicillin-allergic patients, use doxycycline or respiratory fluoroquinolones (levofloxacin, moxifloxacin) 1.